Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 266 | 347 | 656 | 315 | 369 |
| Cost of Goods | 92 | 131 | 246 | 131 | 108 |
| Gross Profit | 174 | 216 | 411 | 184 | 262 |
| Operating Expenses | 1,576 | 2,373 | 2,454 | 3,285 | 1,450 |
| Operating Income | -1,310 | -2,026 | -1,798 | -2,970 | -1,081 |
| Interest Expense | 84 | 149 | 340 | 145 | 263 |
| Other Income | -2 | -85 | -159 | 10 | 80 |
| Pre-tax Income | -1,396 | -2,260 | -2,297 | -3,105 | -1,264 |
| Net Income Continuous | -1,396 | -2,260 | -2,297 | -3,105 | -1,264 |
| Net Income | $-1,396 | $-2,260 | $-2,297 | $-3,105 | $-1,264 |
| EPS Basic Total Ops | -0.05 | -0.09 | -0.24 | -0.42 | -0.18 |
| EPS Basic Continuous Ops | -0.05 | -0.09 | -0.24 | -0.41 | -0.17 |
| EPS Diluted Total Ops | -0.05 | -0.09 | -0.24 | -0.42 | -0.18 |
| EPS Diluted Continuous Ops | -0.05 | -0.09 | -0.24 | -0.41 | -0.17 |
| EBITDA(a) | $-1,217 | $-1,770 | $-1,613 | $-2,538 | $-875 |